Pharmacotherapy of Trigeminal Neuralgia

  • Ayush Agarwal
  • Manjari Tripathi


Trigeminal neuralgia (TGN) is a disorder characterized by brief but severe electric shock-like pain, which is abrupt in onset and termination, and is limited to the distribution of one or more divisions of the trigeminal nerve [1]. It is further sub-classified into classical (CTN) and symptomatic forms (STN), the latter is associated with a demonstrable lesion on imaging apart from a vascular loop [1]. STN should be suspected when a patient presents with bilateral symptoms or concomitant trigeminal sensory loss. The distinction is important as the treatment for both differs.


  1. 1.
    International Headache Society. The international classification of headache disorders: 2nd Edition. Cephalalgia. 2004;24(Suppl 1):9–160.Google Scholar
  2. 2.
    Obermann M. Treatment options in trigeminal neuralgia. Ther Adv Neurol Disord. 2010;3:107–15.CrossRefGoogle Scholar
  3. 3.
    Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29:265–7.CrossRefGoogle Scholar
  4. 4.
    Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neurol. 1968;19:129–36.CrossRefGoogle Scholar
  5. 5.
    Nicol CF. A four year double blind study of tegretol in facial pain. Headache. 1969;9:54–7.CrossRefGoogle Scholar
  6. 6.
    Rockcliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol. 1996;15:129–36.CrossRefGoogle Scholar
  7. 7.
    Kutluay E, McCague K, D’Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003;4:175–80.CrossRefGoogle Scholar
  8. 8.
    Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73:223–30.CrossRefGoogle Scholar
  9. 9.
    Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15:240–4.CrossRefGoogle Scholar
  10. 10.
    Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18:22–7.CrossRefGoogle Scholar
  11. 11.
    Lemos L, Flores S, Oliveira P, Almeida A. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24:64–75.CrossRefGoogle Scholar
  12. 12.
    Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia. 2008;28:174–81.CrossRefGoogle Scholar
  13. 13.
    Domingues RB, Kuster GW, Aquino CC. Treatment of trigeminal neuralgia with low doses of topiramate. Arq Neuropsiquiatr. 2007;65:792–4.CrossRefGoogle Scholar
  14. 14.
    Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam in treatment of patients with trigeminal neuralgia. Eur J Neurol. 2009;16:740–4.CrossRefGoogle Scholar
  15. 15.
    Desai N, Shah K, Gandhi I. Baclofen sodium valproate combination in carbamazepine resistant trigeminal neuralgia: a double blind clinical trial. Cephalalgia. 1991;II(Suppl):321–2.CrossRefGoogle Scholar
  16. 16.
    Carasso RL, Yehuda S, Streifler M. Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci. 1979;9:191–4.CrossRefGoogle Scholar
  17. 17.
    Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, Nurmikko T, Zakrzewska JM, American Academy of Neurology Society, European Federation of Neurological Society. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15:1013–28.CrossRefGoogle Scholar
  18. 18.
    William P. Cheshire. Trigeminal neuralgia: a guide to drug choice. CNS Drugs. 1997;7:98–110.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Ayush Agarwal
    • 1
  • Manjari Tripathi
    • 1
  1. 1.Department of NeurologyAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations